(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Carey S. Cadieux, Binghamton University, State University of New York (THE ...
The US’s reclassification of cannabis under a “less dangerous” drug schedule is part of a broader trend towards legitimising ...
The Department of Justice’s push to reclassify marijuana as a Schedule III drug Thursday provided an immediate jolt on Wall Street for a group of publicly traded cannabis companies, as the Biden ...
Not yet. While numerous media outlets reported that President Trump’s executive order reclassified marijuana from a Schedule I controlled substance to a Schedule III controlled substance, it did ...
For decades, the federal government has classified cannabis as a Schedule I substance, deeming it to have a "high potential for abuse" and "no currently accepted medical use in treatment" in the ...
Hosted on MSN
Reclassification of marijuana opens doors for much-needed medical research into the benefits and risks of the drug
When the U.S. Department of Justice moved to reclassify medical marijuana to a Schedule III drug on April 23, 2026, it set the stage for a vast amount of medical research that has been hobbled for ...
Credit: Getty Images The new federal classification of marijuana regulates only medical use; recreational use is still determined by state laws. The Conversation — When the US Department of Justice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results